We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$2.09M
AUM Growth
-$1.71B
Cap. Flow
+$165M
Cap. Flow %
7,891.97%
Top 10 Hldgs %
17.5%
Holding
608
New
19
Increased
238
Reduced
260
Closed
18

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.16M
2
IBM icon
IBM
IBM
+$7.08M
3
PLD icon
Prologis
PLD
+$6.1M
4
ED icon
Consolidated Edison
ED
+$5.19M
5
CAH icon
Cardinal Health
CAH
+$5.05M

Sector Composition

Rank Sector Weight
1 Real Estate 15.58%
2 Technology 13.6%
3 Healthcare 13.3%
4 Industrials 13.09%
5 Consumer Staples 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
376
Microchip Technology
MCHP
$43.4B
$684 0.03%
9,732
-273
-3% -$18.8K
OUT icon
377
Outfront Media
OUT
$5.3B
$683 0.03%
41,882
MAC icon
378
Macerich
MAC
$6.95B
$682 0.03%
60,578
TEL icon
379
TE Connectivity
TEL
$62.2B
$680 0.03%
5,927
-1,340
-18% -$159K
EIX icon
380
Edison International
EIX
$26.6B
$673 0.03%
10,578
+10
+0.1% +$614
LNT icon
381
Alliant Energy
LNT
$18.2B
$668 0.03%
12,100
+240
+2% +$12.8K
BSX icon
382
Boston Scientific
BSX
$74.9B
$666 0.03%
14,391
-1,618
-10% -$70.1K
AMP icon
383
Ameriprise Financial
AMP
$49.8B
$650 0.03%
2,087
-1,015
-33% -$310K
PODD icon
384
Insulet
PODD
$10B
$650 0.03%
2,208
-30
-1% -$8.27K
KLAC icon
385
KLA
KLAC
$272B
$647 0.03%
17,150
-1,700
-9% -$59.2K
STZ icon
386
Constellation Brands
STZ
$22.9B
$647 0.03%
2,792
-90
-3% -$21.5K
NVR icon
387
NVR
NVR
$16.8B
$646 0.03%
140
-8
-5% -$35.2K
ANET icon
388
Arista Networks
ANET
$264B
$641 0.03%
21,136
-16,640
-44% -$512K
HPE icon
389
Hewlett Packard
HPE
$76.9B
$636 0.03%
39,876
+570
+1% +$8.4K
MRNA icon
390
Moderna
MRNA
$25.6B
$626 0.03%
3,485
-210
-6% -$34.3K
BFAM icon
391
Bright Horizons
BFAM
$3.74B
$625 0.03%
9,901
CE icon
392
Celanese
CE
$4.8B
$624 0.03%
6,100
+100
+2% +$9.92K
OXY icon
393
Occidental Petroleum
OXY
$58.6B
$622 0.03%
9,876
-380
-4% -$25.9K
NHI icon
394
National Health Investors
NHI
$3.48B
$614 0.03%
11,755
-370
-3% -$20.3K
DVN icon
395
Devon Energy
DVN
$49.4B
$613 0.03%
9,970
-2,310
-19% -$157K
SLG icon
396
SL Green Realty
SLG
$4.01B
$612 0.03%
18,163
FCPT icon
397
Four Corners Property Trust
FCPT
$2.73B
$611 0.03%
23,548
+629
+3% +$16.2K
NTAP icon
398
NetApp
NTAP
$39.5B
$607 0.03%
10,102
+3,036
+43% +$201K
LYB icon
399
LyondellBasell Industries
LYB
$20.3B
$605 0.03%
7,290
+90
+1% +$7.37K
PINS icon
400
Pinterest
PINS
$13B
$598 0.03%
24,634

Similar funds

Meiji Yasuda Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Meiji Yasuda Asset Management held 608 positions worth $2.09M, down 100% from $1.71B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Meiji Yasuda Asset Management deployed $165M of net new capital in Q4 2022, opening 19 new positions and adding to 238 existing holdings. Its largest new stake was First Horizon: 94,620 shares worth $2.32K.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $3.3M trimmed.

  • Meiji Yasuda Asset Management's largest Q4 2022 buy was First Horizon: 94,620 shares worth $2.32K.
  • Meiji Yasuda Asset Management added most to AbbVie in Q4 2022, an estimated $7.16M increase.
  • Meiji Yasuda Asset Management's biggest Q4 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $3.3M.
  • Meiji Yasuda Asset Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $5.65M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 17% of its $2.09M portfolio in Q4 2022.
  • Meiji Yasuda Asset Management opened 19 new positions and closed 18 in Q4 2022.
  • Meiji Yasuda Asset Management's portfolio value fell 100% quarter-over-quarter to $2.09M.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.